Perrigo’s Next CEO Has Long OTC Brands History

Lockwood-Taylor Moves From Bayer As Perrigo Awaits Decision On OTC Oral Contraceptive

Patrick Lockwood-Taylor starts as president/CEO on 30 June, succeeding Murray Kessler as Perrigo awaits FDA decision on subsidiary HRA’s proposal for first US OTC sales of daily oral contraceptive. He’s moving from president of Bayer AG’s US business and regional president, consumer health North America.

• Source: Shutterstock

Perrigo Company PLC’s transition from leading the OTC drug private label/store brand space to also competing in branded consumer health product sales will be in the hands of an industry veteran with experience at two firms behind some of the most well-known global brands.

Perrigo firm on 8 June announced Patrick Lockwood-Taylor will start as president and CEO on 30 June, succeeding Murray Kessler...

More from Leadership

More from HBW Insight